Celgen Biopharmaceuticals' Unattributed VC Round

Celgen Biopharmaceuticals raised a round of funding on July 02, 2009. Investors include China-Israel Value Capital.

Shanghai Celgen Biopharmaceutical is a bio-similar biopharmaceuticals drugs developer and manufacture in China mainly focused on Inflammation, Oncology and Metabolic Disease. Celgen's main product is …

Articles about Celgen Biopharmaceuticals' Unattributed VC Round: